March 28, 2020 01:13 pm | Updated 01:47 pm IST
File photo of Nivaquine, tablets containing chloroquine, a commonly used malaria drug that has shown signs of effectiveness against coronavirus.
Hydroxychloroquine is now a schedule H1 drug, and can be sold on prescription only.
According to a gazette notification issued by the Union Health Ministry, the sale of the drug from now on should be in accordance with the conditions for sale of drugs specified in Schedule H1 to the Drugs and Cosmetics Rules, 1945. Here is the official notification:
Health and Family Welfare Ministry’s notification on ‘hydroxychloroquine’
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
